arrow
P

Priya S. Kishnani

Duke University
H指数:75
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Detection of Down Syndrome Arthritis in Clinical Practice: A Multicenter, International Pilot and Feasibility Study of a Down Syndrome-Specific Musculoskeletal Screening Tool

唐氏综合征关节炎的临床检测:一项关于唐氏综合征特异性肌肉骨骼筛查工具的多中心、国际性试点与可行性研究

2025-11-010
PRE
Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants

低磷酸酯酶症患者携带ALPL变异体的生化表型

2025-10-010
OAAI
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial

avalglucosidase alfa在COMET试验中治疗晚期发作型庞贝病145周后的疗效与安全性

2025-08-160
OA
Correction: Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry

更正:使用α-葡糖苷酶治疗晚发型庞贝病患者13年内用力肺活量的变化:庞贝病登记注册真实世界数据的新建模

2025-07-310
OAAI
The Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treated with Alglucosidase Alfa

Mini-COMET临床研究:Avalglucosidase Alfa在先前接受Alglucosidase Alfa治疗的婴儿型糖原贮积症I型患儿中97周治疗的安全性与有效性

2025-05-290
PRE
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

将晚期庞贝病糖苷酶替代疗法从阿糖苷酶alfa切换为西帕糖苷酶alfa联合米格鲁斯坦:PROPEL研究的后效分析

2025-05-070
OA